First Patient Treated in Phase 2 GvHD Trial

Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, c...

 March 06, 2024 | News

Telix Pharmaceuticals Acquires ARTMS Inc. to Revolutionize Radioisotope Production

Telix Pharmaceuticals announced its acquisition of radioisotope production technology firm ARTMS Inc. ("ARTMS"), including its advanced cyclotron-based iso...

 March 05, 2024 | News

Bridging Gaps, Building Futures: Ruth Kuguru’s Approach to Healthcare Solutions in APAC

In this insightful interview with BioPharma APAC, Ruth Kuguru, Executive Director of Communications & Engagement at Novartis for Asia Pacific, Middle E...

 March 05, 2024 | Interaction

Innovent Begins Phase 1 Trial of IBI3002 in Australia

  This FIH study (NCT06213844) is a randomized, double-blind, placebo-controlled, single ascending dose (SAD) study to evaluate the safety, tolerabil...

 March 01, 2024 | News

BioCina and NovaCina Join Forces for Integrated Biologics Solutions

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish...

 February 28, 2024 | News

Australian Telix Boosts US Presence with IsoTherapeutics Acquisition

Founded in 2005, IsoTherapeutics is a privately held, commercial-stage company, which provides radiochemistry and bioconjugation development and contract m...

 February 27, 2024 | News

Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics

  Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...

 February 26, 2024 | News

Cure Brain Cancer Foundation CEO Lance Kawaguchi Triumphs in SouthPoleTrek4Cancer, Raising Over $1 Million

     Lance Kawaguchi, the dynamic CEO of Cure Brain Cancer Foundation, has achieved an extraordinary milestone by ...

 February 26, 2024 | News

Sparsentan Receives CHMP Endorsement for IgA Nephropathy Treatment in Europe

CSL Vifor together with Travere Therapeutics, Inc., disclosed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CH...

 February 26, 2024 | News

AIRS Medical Partners with ParagonCare to Boost SwiftMR™ Sales in Australia and New Zealand

AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, has announced a strategic partnership agreement with ParagonCare Limited&nbs...

 February 19, 2024 | News

Biointelect and CR2O Partner to Revolutionize Global Life Science Commercialization

Biointelect and CR2O have announced a strategic partnership aimed at delivering comprehensive commercialization solutions. This collaboration marks a miles...

 February 15, 2024 | News

Biocon Biologics Teams Up with Sandoz Australia for Biosimilar Trastuzumab and Bevacizumab

Under the agreement, Sandoz will distribute the Biocon Biologics' brands, OGIVRI® (bTrastuzumab) and ABEVMY® (bBevacizumab), and facilita...

 February 09, 2024 | News

Aurora Cannabis Expands Global Footprint with Acquisition of MedReleaf Australia

  MedReleaf Australia, holding the coveted #2 spot in the rapidly growing Australian medical cannabis market, was acquired by Aurora in a transaction...

 February 09, 2024 | News

Telix to Acquire QSAM Biosciences, Bolstering Bone Cancer Targeting

  153Sm-DOTMP utilizes a cutting-edge chelating agent to deliver Samarium-153 radioisotope, offering potential advancements in bone cancer treatment....

 February 08, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in